Foster & Motley Inc. Decreases Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Foster & Motley Inc. decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,552 shares of the pharmacy operator’s stock after selling 3,539 shares during the quarter. Foster & Motley Inc.’s holdings in Walgreens Boots Alliance were worth $563,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Dark Forest Capital Management LP raised its position in shares of Walgreens Boots Alliance by 6.5% during the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 1,804 shares during the last quarter. Deutsche Bank AG raised its holdings in Walgreens Boots Alliance by 36.2% in the 3rd quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock valued at $48,269,000 after acquiring an additional 576,534 shares during the last quarter. Van ECK Associates Corp raised its holdings in Walgreens Boots Alliance by 28.2% in the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock valued at $2,873,000 after acquiring an additional 28,400 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Walgreens Boots Alliance by 3.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock valued at $32,130,000 after acquiring an additional 47,071 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after acquiring an additional 10,962,030 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of several analyst reports. Truist Financial reiterated a “hold” rating and issued a $25.00 price target on shares of Walgreens Boots Alliance in a report on Monday, April 1st. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, Barclays initiated coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $24.36.

Insider Activity

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was purchased at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders purchased 13,456 shares of company stock worth $270,423 over the last three months. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $18.05 on Wednesday. The firm’s 50 day moving average is $20.26 and its two-hundred day moving average is $21.86. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $35.54. The firm has a market capitalization of $15.57 billion, a P/E ratio of -2.58, a PEG ratio of 1.13 and a beta of 0.73. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $1.16 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.